TP53 and urinary bladder carcinoma: This fits previous findings that WWOX inhibits the clonogenicity of bladder cancer [47] but also pancreatic carcinoma via triggering apoptosis in a p53-dependent mechanism [65] or leukemia by the release of cytochrome c [66].